BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Daiichi Sankyo

Generated: February 20, 2018

DrugPatentWatch Database Preview

Details for Patent: ➤ Try a Free Trial

« Back to Dashboard

Details for Patent: ➤ Try a Free Trial

Abstract:Certain 11-basically substituted dibenz[b,f][1,4]oxazepines are useful as anti-emetics. 3 Claims, No Drawings
Inventor(s): Jean Schmutz, Pourtalesstrasse 36 (Muri, CH), Fritz Hunziker, Wabernstrasse 53 (Berne, CH), Franz Martin Kunzle, Landoltstrasse 11 (Berne, CH)
Filing Date:Jul 16, 1970
Application Number:05/055,602
Claims:1. A method for treating emesis, which comprises enterally or parenterally administering to a mammal in need of said treatment a compound of the formula: ##SPC4## and pharmaceutically acceptable acid addition salts thereof where R.sub.1 represents hydrogen, allyl, alkyl containing not more than three carbon atoms, hydroxyalkyl containing not more than three carbon atoms, alkoxyalkyl containing not more than six carbon atoms or alkoyloxy-alkyl containing not more than six carbon atoms and R.sub.2 and R.sub.3 are the same or different and represent hydrogen or methyl, at a daily dosage of

2. A method according to claim 1 in which the compound is 2-dimethylaminosulphonyl-11-(4-methyl-1-piperazinyl)- dibenz[b,f][1,4]oxaze

3. A method according to claim 1 wherein the compound is administered to a mammal in need of said treatment in a unit dosage form comprising said compound to the extent of from about 10 milligrams to about 25 milligrams per unit dosage.
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Farmers Insurance
Johnson and Johnson
US Department of Justice
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: